Market Place
Sourcing Support
Enforcement Report - Week of June 18, 2025
18 Jun 2025 //
FDA
Enforcement Report - Week of June 11, 2025
11 Jun 2025 //
FDA
Amish Origins Recieves Management Warning Letter
10 Jun 2025 //
FDA
Laboratoire Druide Recieves Warning Letter
10 Jun 2025 //
FDA
Health Canada Issues Recalls of Laboratoire Riva`s Rivasa Tablet
06 Jun 2025 //
HEALTH CANADA
Health Canada Issues Recalls of Baxter`s NaCl injection
06 Jun 2025 //
HEALTH CANADA
Health Canada Issues Recalls of Teva`s Seasonique tablet
06 Jun 2025 //
HEALTH CANADA
Health Canada Issues Recalls of Teva`s Seasonale Tablet
06 Jun 2025 //
HEALTH CANADA
Church & Dwight Recalls Zicam and Orajel Swabs Over Contamination
06 Jun 2025 //
FDA
Enforcement Report - Week of June 4, 2025
04 Jun 2025 //
FDA
Amneal Nationwide Recalls Sulfamethoxazole Trimethoprim Tablets
04 Jun 2025 //
FDA
Rechon Life Science Recieves Warning Letter
03 Jun 2025 //
FDA
CTK OTC Laboratories Recieves Warning Letter
03 Jun 2025 //
FDA
Yiling Pharmaceutical Recieves Warning Letter
03 Jun 2025 //
FDA
Evi Labs Recieves Warning Letter
03 Jun 2025 //
FDA
Zhejiang Easyclean Daily Chemical Recieves Warning Letter
03 Jun 2025 //
FDA
Health Canada Issues Recalls of Sanis Health`s Moxifloxacin
02 Jun 2025 //
HEALTH CANDA
Enforcement Report - Week of May 28, 2025
28 May 2025 //
FDA
Everlaan Organics is on FDA Import Alert List
23 May 2025 //
FDA
Umary Issues a Nationwide Recall of Unavy Acidio Hialuronico
22 May 2025 //
FDA
Enforcement Report - Week of May 21, 2025
21 May 2025 //
FDA
Skye Biologics Recieves Warning Letter
20 May 2025 //
FDA
NWL Netherlands Service Recieves Warning Letter
20 May 2025 //
FDA
Wuxi Medical Instrument Recieves Warning Letter
20 May 2025 //
FDA
Sarfez Pharma Recieves Warning Letter
20 May 2025 //
FDA
Product Society Recieves Warning Letter
20 May 2025 //
FDA
Vinlab Pharma Limited`s Fails EDQM inspection
15 May 2025 //
EMA
Enforcement Report - Week of May 14, 2025
14 May 2025 //
FDA
Sun Pharma is on FDA Import Alert List with Recent update
12 May 2025 //
FDA
Enforcement Report - Week of May 7, 2025.pdf
07 May 2025 //
FDA
Nana Barseghian Recieves Warning Letter
06 May 2025 //
FDA
Nectar Life Sciences Limited`s Fails EDQM inspection
05 May 2025 //
EMA
Health Canada Issues Recalls of Jamp`s JAMP-Pregabalin
05 May 2025 //
HEALTH CANADA
Health Canada Issues Recalls of Jamp`s JAMP-Pentoxifylline
05 May 2025 //
HEALTH CANADA
Enforcement Report - Week of April 30, 2025
30 Apr 2025 //
FDA
Beo Pharmaceuticals Receives FDA Warning Letter
29 Apr 2025 //
FDA
Dyno Manufacturing Receives FDA Warning Letter
29 Apr 2025 //
FDA
Cosco International Receives FDA Warning Letter
29 Apr 2025 //
FDA
Enforcement Report - Week of April 23, 2025
23 Apr 2025 //
FDA
Amneal Issues a Nationwide Recall of Ropivacaine HCl
18 Apr 2025 //
FDA
FDA Issues Form 483 to Zhejiang Huahai Pharmaceutical
16 Apr 2025 //
FDA
Enforcement Report - Week of April 16, 2025
16 Apr 2025 //
FDA
PMS4PMS Receives FDA Warning Letter
15 Apr 2025 //
FDA
Health Canada Issues Recalls of Riva`s Acetaminophen
15 Apr 2025 //
HEALTH CANADA
Health Canada Issues Recalls of Riva`s NRA-Quetiapine
11 Apr 2025 //
HEALTH CANADA
FDA Issues Form 483 to Aurolife Pharma
10 Apr 2025 //
FDA
Health Canada Issues Recalls of Teva`s Teva 5-ASA
07 Apr 2025 //
HEALTH CANADA
Enforcement Report - Week of April 2, 2025
02 Apr 2025 //
FDA
FDA Issues Form 483 to Laboratorios Farmaceuticos Rovi
28 Mar 2025 //
FDA
FDA Issues Form 483 to Suzhou Suncadia Biopharma
28 Mar 2025 //
FDA
FDA Issues Form 483 to Palmetto Isotopes LLC
28 Mar 2025 //
FDA
FDA Issues Form 483 to SKNV
28 Mar 2025 //
FDA
FDA Issues Form 483 to Eagle Pharma Outsourcing LLC
28 Mar 2025 //
FDA
FDA Issues Form 483 to Revive Rx LLC
28 Mar 2025 //
FDA
Health Canada Issues Recalls of Mint Pharma`s Rosuvastatin
26 Mar 2025 //
HEALTH CANADA
Enforcement Report - Week of March 26, 2025
26 Mar 2025 //
FDA
Yangzhou Sion Receives FDA Warning Letter
25 Mar 2025 //
FDA
Hangzhou Glamcos Biotech Receives FDA Warning Letter
25 Mar 2025 //
FDA
FDA Issues Form 483 to Eli Lilly & Company
24 Mar 2025 //
FDA
FDA Issues Form 483 to UCB Pharma SA
24 Mar 2025 //
FDA
